Loading chart…
PRE-MARKET
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers mammography, stress tests, dual-energy X-ray absorptiometry scans, bone mineral density tests, computed tomography scans, and magnetic resonance imaging services, as well as tele-radiology and tele-pathology services. The company was incorporated in 2010 and is based in Pune, India.
Krsnaa Diagnostics Limited (KRSNAA) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The KRSNAA share price is ₹475.00 (-1.86% today), with a market capitalisation of ₹16B and a price-to-earnings (P/E) ratio of 15.9. MarketRipple tracks the KRSNAA investment thesis, the ripple-chain impact of market events on Krsnaa Diagnostics Limited, and the Healthcare sector outlook.
Open
₹479.00
High
₹484.95
Low
₹470.00
Prev. Close
₹484.00
52W High
₹838.00
52W Low
₹463.10
Day range
₹470.00–₹484.95
52-week range
₹463.10–₹838.00
Volume
54K
P/E
15.9
ROE
10.3%
D/E
0.55
Margin
11.6%
Krsnaa Diagnostics Limited (NSE: KRSNAA) is currently trading at ₹475.00 (-1.86%).
Krsnaa Diagnostics Limited's market capitalization is ₹16B.
Krsnaa Diagnostics Limited's price-to-earnings (P/E) ratio is 15.9.
Krsnaa Diagnostics Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Krsnaa Diagnostics Limited currently reads neutral, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.